Marketing-authorisation holder · United States
Supernus Pharms
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| GOCOVRI137mg base | 68.5mg base · Capsule, extended release | Amantadine | United States | Marketed | 2017 |
| OSMOLEX ER129mg base | 161mg base | 193mg base | 258mg base · Tablet, extended release | Amantadine | United States | Not marketed | 2018 |
| OXTELLAR XR150mg | 300mg | 600mg · Tablet, extended release | Oxcarbazepine | United States | Marketed | 2012 |
| QELBREE100mg base | 150mg base | 200mg base · Capsule, extended release | Viloxazine | United States | Marketed | 2021 |
| TROKENDI XR100mg | 200mg | 25mg | 50mg · Capsule, extended release | Topiramate | United States | Marketed | 2013 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 | 0 | Companies |



